« Back to results
  • Added 9 Jun 2013

Laboratory for Public Health Research Biotechnologies

Experience

4 Community Sites characterised

9 Clinical Trials.

Of these, 5 randomised malaria drug trials, three investigator initiated among which one was open label and sponsored by WHO/TDR, two company sponsored, two multicountry trials of which one was a cluster randomised cost effectiveness trial and the other was a double blinded community study investigating nutrition intervention on malaria incidence and gastro-respiratory related morbidity.

Research interests

Malaria, Molecular Epidemiology, Clinical Trials, TB and Respiratory Infections Molecular Diagnostics, Phytotherapy.

Bioactive Peptides of Extremophiles.

Biological factors influencing drug response in human infectious disease treatment.


Disease areas

  • Malaria
  • TB

Other information

Our site also carries out regional training for Good Clinical Laboratory Practice and Research Techniques in the Molecular Biosciences. We are als.o a regional trianing site for the IAEA RAF research programme.

Our Laboratory has past or current links with the following consortium or networks

Current: IAEA, EViMaLAR, ACT Consortium at LSHTM, MCDC, Poverty Related Diseases College, RESTAGMI Network

Past: Gates Malaria Partnership at LSHTM

Contact this site

To: Prof Wilfred F. Mbacham, Principal Investigator and Lab Director at Laboratory for Public Health Research Biotechnologies

Please Login to contact a site.